Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact

September 2023

  • Home
  • 2023
  • September
Events

Great success at Eurovalve 2023 !

Sep 29, 2023
READ MORE
Events

Cardiawave at Medicen Day 2023 – Sept. 26 – Paris, France

Sep 25, 2023
READ MORE
Events

Cardiawave at Eurovalve Congress 2023 – Sept. 22 – Milan, Italy

Sep 19, 2023

© CNRS

READ MORE

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Other news
  • Press Release
  • Scientific Publications

l Latest news

  • VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking
  • VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l April 28th 2025
  • Legal Mentions